Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BiltRx vs VivioMD

By GLP-1 ScorecardUpdated

BiltRxFactor scores not reassessed.
Site position #59

Higher score

VivioMDFactor scores not reassessed.
Site position #434

Lower score

Score comparison

BiltRx has the higher recorded score — 75.3/100 to 57.4/100.

BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.

Before you choose

VivioMD does not publish a semaglutide price, so its VivioMD review sets out what it does disclose, while the BiltRx review explains the conditions attached to BiltRx's figure. The semaglutide cost page compares published rates across the field. Ask VivioMD for a written total before treating either one as the cheaper choice.

If neither one fits, BiltRx vs Vytora Health and CoreAge Rx vs VivioMD compare each of them with another graded program, and the list of alternatives to BiltRx ranks the programs closest to BiltRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueBiltRx +46
91
45
Dose & formulationBiltRx +9
85
76
Clinical oversightBiltRx +19
74
55
Labs & monitoringVivioMD +1
52
53
FulfillmentVivioMD +10
71
81
Contract termsBiltRx +26
55
29
BiltRx · top barVivioMD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBiltRxVivioMD
WeighScore75.3/10057.4/100
GradeCC
Site position#59#434
Semaglutide$82/mo advertised medication starting price; confirm care and shipping chargesNot disclosed
Tirzepatide$130/mo advertised medication starting price; confirm care and shipping chargesNot disclosed
CoverageAll 50 states advertisedTerms exclude Louisiana; homepage advertises providers in all 50 states
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
BiltRx

Site position #59 · C

Factor scores not reassessed.

Strengths

  • Publishes 12-week package totals
  • Explains the consultation charge if treatment is declined

What to consider

  • Confirm whether consultation and shipping are included in the selected plan
  • Renewal cancellation does not refund an approved order
VivioMD

Site position #434 · C

Factor scores not reassessed.

FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.

Strengths

  • Terms identify OpenLoop clinical groups and list RedRock, Health Warehouse and Triad Rx
  • Public refund policy states the renewal cancellation cutoff

What to consider

  • Reviewed homepage does not show drug-specific pricing
  • Terms exclude Louisiana despite nationwide provider language
  • Cancellation requests must arrive at least 72 hours before the next bill
  • Compounded medications are not FDA-approved

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard